-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In a new study, researchers from Weill Cornell Medical College have discovered that a genetic mutation linked to Alzheimer's disease alters signaling pathways in certain immune cells in Alzheimer's patients
The study focused on microglia, the immune cells in the central nervous system that are the first to respond when something goes wrong in the brain
Alzheimer's disease is the most common neurodegenerative disease of aging, affecting approximately 46 million people worldwide
Single-cell RNA-seq analysis of microglial responses in a mouse model of Alzheimer's disease
Image via Science Translational Medicine, 2021, doi:DOI: 10.
To study how microglia in the brain might contribute to Alzheimer's disease, Dr.
Importantly, since AKT signaling also contributes to the pathogenesis of many types of cancer, MK-2206 is currently being evaluated in multiple cancer clinical trials
Note: The original text has been deleted
References:
Faten A.